|
1
|
Vinogradova Y, Hippisley-Cox J, Coupland
C, et al: Risk of colorectal cancer in patients prescribed statins,
nonsteroidal anti-inflammatory drugs, and cyclooxygenase-2
inhibitors: nested case-control study. Gastroenterology.
133:393–402. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Doherty GA and Murray FE: Cyclooxygenase
as a target for chemoprevention in colorectal cancer: lost cause or
a concept coming of age? Expert Opin Ther Targets. 13:209–218.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rostom A, Dube C, Lewin G, et al:
Nonsteroidal anti-inflammatory drugs and cyclooxygenase-2
inhibitors for primary prevention of colorectal cancer: a
systematic review prepared for the U.S. Preventive Services Task
Force. Ann Intern Med. 146:376–389. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Rothwell PM, Price JF, Fowkes FG, et al:
Short-term effects of daily aspirin on cancer incidence, mortality,
and non-vascular death: analysis of the time course of risk sand
benefits in 51 randomised controlled trials. Lancet. 379:1602–1612.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li S, Miner K, Fannin R, et al:
Cyclooxygenase-1 and 2 in normal and malignant human ovarian
epithelium. Gynecol Oncol. 92:622–627. 2004. View Article : Google Scholar
|
|
6
|
Thun MJ, Henley SJ and Patrono C:
Nonsteroidal anti-inflammatory drugs as anticancer agents:
mechanistic, pharmacologic, and clinical issues. J Natl Cancer
Inst. 94:252–266. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Dube C, Rostom A, Lewin G, et al: The use
of aspirin for primary prevention of colorectal cancer: a
systematic review prepared for the U.S. Preventive Services Task
Force. Ann Intern Med. 146:365–375. 2007. View Article : Google Scholar
|
|
8
|
Sadeghi S, Bain CJ, Pandeya N, et al:
Aspirin, nonsteroidal anti-inflammatory drugs, and the risks of
cancers of the esophagus. Cancer Epidemiol Biomarkers Prev.
17:1169–1178. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gee JR, Jarrard DF, Bruskewitz RC, et al:
Reduced bladder cancer recurrence rate with cardioprotective
aspirin after intravesical bacille Calmette-Guerin. BJU Int.
103:736–739. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kelly JP, Coogan P, Strom BL, et al: Lung
cancer and regular use of aspirin and nonaspirin nonsteroidal
anti-inflammatory drugs. Pharmacoepidemiol Drug Saf. 17:322–327.
2008. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Alfonso LF, Srivenugopal KS, Arumugam TV,
et al: Aspirin inhibits camptothecin-induced p21CIP1
levels and potentiates apoptosis in human breast cancer cells. Int
J Oncol. 34:597–608. 2009.PubMed/NCBI
|
|
12
|
Kim SR, Bae MK, Kim JY, et al: Aspirin
induces apoptosis through the blockade of IL-6-STAT3 signaling
pathway in human glioblastoma A172 cells. Biochem Biophys Res
Communm. 387:342–347. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Iwama T: NSAIDs and colorectal cancer
prevention. J Gastroenterol. 44:72–76. 2009. View Article : Google Scholar
|
|
14
|
Dannenberg AJ, Altorki NK, Boyle JO, et
al: Cyclo-oxygenase 2: a pharmacological target for the prevention
of cancer. Lancet Oncol. 2:544–551. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang D, Mann JR and DuBois RN: The role of
prostaglandins and other eicosanoids in the gastrointestinal tract.
Gastroenterology. 128:1445–1461. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Alitalo K, Tammela T and Petrova TV:
Lymphangiogenesis in development and human disease. Nature.
438:946–953. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Achen MG and Stacker SA: Tumor
lymphagiogenesis and metastatic spread-new players begin to emerge.
Int J Cancer. 119:1755–1760. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Pepper MS, Tille JC, Nisato R, et al:
Lymphangiogenesis and tumor metastasis. Cell Tissue Res.
314:167–177. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yonemura Y, Endo Y, Fujita H, et al: Role
of vascular endothelial growth factor C expression in the
development of lymph node metastasis in gastric cancer. Clin Cancer
Res. 5:1823–1829. 1999.PubMed/NCBI
|
|
20
|
Su JL, Shih JY, Yen ML, et al:
Cyclooxygenase-2 induces EP1- and HER-2/Neu-dependent vascular
endothelial growth factor-C up-regulation: a novel mechanism of
lymphangiogenesis in lung adenocarcinoma. Cancer Res. 64:554–564.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Timoshenko AV, Chakraborty C, Wagner GF,
et al: COX-2-mediated stimulation of the lymphangiogenic factor
VEGF-C in human breast cancer. Br J Cancer. 94:1154–1163. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Siironen P, Ristimaki A, Narko K, et al:
VEGF-C and COX-2 expression in papillary thyroid cancer. Endocr
Relat Cancer. 13:465–473. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Soumaoro LT, Uetake H, Takagi Y, et al:
Coexpression of VEGF-C and Cox-2 in human colorectal cancer and its
association with lymph node metastasis. Dis Colon Rectum.
49:392–398. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang J, Ji J, Yuan F, et al:
Cyclooxygenase-2 expression is associated with VEGF-C and lymph
node metastases in gastric cancer patients. Biomed Pharmacother.
59:S285–S288. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Weider N, Carroll PR, Flax J, et al: Tumor
angiogenesis correlation with metastasis in invasive prostate
carcinoma. Am J Pathol. 143:755–761. 1993.
|
|
26
|
Borthwick GM, Johnson AS, Partington M, et
al: Therapeutic levels of aspirin and salicylate directly inhibit a
model of angiogenesis through a Cox-independent mechanism. FASEB J.
20:2009–2016. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Pillinger MH, Capodici C, Rosenthal P, et
al: Modes of action of aspirin-like drugs: salicylates inhibit erk
activation and integrin-dependent neutrophil adhesion. Proc Natl
Acad Sci USA. 95:14540–14545. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Saad RS, Kordunsky L, Liu YL, et al:
Lymphatic microvessel density as prognostic marker in colorectal
cancer. Mod Pathol. 19:1317–1323. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
lwata C, Kano MR, Komuro A, et al:
Inhibition of cyclooxygenase-2 suppresses lymph node metastasis via
reduction of lymphangiogenesis. Cancer Res. 67:10181–10189. 2007.
View Article : Google Scholar : PubMed/NCBI
|
